Literature DB >> 15808881

Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.

Haiyan Jin1, Isao Sakaida, Masako Tsuchiya, Kiwamu Okita.   

Abstract

The aim of this study was to investigate whether herbal medicine Rhei rhizome, extract powder from herbs, has influences on the development of liver fibrosis. In in vivo studies the effects of Rhei rhizome were examined using the choline-deficient L-amino acid-defined (CDAA) diet-induced liver fibrosis model. In In vitro studies the effects of Rhei rhizome on type I procollagen mRNA expression, alpha-smooth muscle actin (alpha-SMA), metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) of isolated hepatic stellate cell were examined. In vivo Rhei rhizome prevented fibrosis in a dose-dependent manner up to 1.0% (w/w) with a reduced number of activated stellate cells. In vitro the Rhei rhizome prevented stellate cell activation resulting in reduced type I procollagen mRNA, alpha-SMA and TIMP-1, 2 expression. These results indicate that Rhei rhizome significantly reduces liver fibrosis by the direct inhibition of stellate cell activation without reducing hepatocyte cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808881     DOI: 10.1016/j.lfs.2004.09.041

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis.

Authors:  Haiyan Jin; Shuji Terai; Isao Sakaida
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Effects of traditional Chinese herbal medicine San-Huang-Xie-Xin-Tang on gastrointestinal motility in mice.

Authors:  Min Woo Hwang; Tae Seok Ahn; Noo Ri Hong; Han-Sol Jeong; Myeong Ho Jung; Ki-Tae Ha; Byung Joo Kim
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

3.  Inhibition of the tubular epithelial-to-mesenchymal transition in vivo and in vitro by the Uremic Clearance Granule ().

Authors:  Zhao-yu Lu; Shu-wen Liu; Yuan-sheng Xie; Shao-yuan Cui; Xu-sheng Liu; Wen-jia Geng; Xiao Hu; Jia-yao Ji; Xiang-mei Chen
Journal:  Chin J Integr Med       Date:  2013-12-05       Impact factor: 1.978

4.  Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury.

Authors:  Jia-bo Wang; Hai-ping Zhao; Yan-ling Zhao; Cheng Jin; Dao-jian Liu; Wei-jun Kong; Fang Fang; Lin Zhang; Hong-juan Wang; Xiao-he Xiao
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

5.  Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease.

Authors:  Wei Mao; Lei Zhang; Chuan Zou; Chuang Li; Yifan Wu; Guobin Su; Xinfeng Guo; Yuchi Wu; Fuhua Lu; Qizhan Lin; Lixin Wang; Kun Bao; Peng Xu; Daixin Zhao; Yu Peng; Hui Liang; Zhaoyu Lu; Yanxiang Gao; Xina Jie; La Zhang; Zehuai Wen; Xusheng Liu
Journal:  BMC Complement Altern Med       Date:  2015-09-08       Impact factor: 3.659

6.  Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan.

Authors:  Fuu-Jen Tsai; Pei-Yuu Yang; Chao-Jung Chen; Ju-Pi Li; Te-Mao Li; Jian-Shiun Chiou; Chi-Fung Cheng; Po-Heng Chuang; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Bo Ban; Wen-Miin Liang; Ying-Ju Lin
Journal:  BMC Complement Med Ther       Date:  2020-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.